Interés Humano

Vacunas muestran alta eficacia contra casos graves de ómicron, según datos de EE. UU.

Las vacunas y dosis de refuerzo contra la covid-19 siguieron teniendo una eficacia muy alta contra las consecuencias graves de la enfermedad a pesar de la nueva variante ómicron

People wait to receive a dose of the Pfizer-BioNTech vaccine against COVID-19 at a vaccination center in Santiago, on January 20, 2022. - Chile registered this Thursday a new record of daily infections, with 12,500 new infected, the highest number in the entire pandemic, in one of the countries with the highest percentage of its population vaccinated and that this Thursday began to apply the fourth dose to health personnel. (Photo by JAVIER TORRES / AFP)
People wait to receive a dose of the Pfizer-BioNTech vaccine against COVID-19 at a vaccination center in Santiago, on January 20, 2022. - Chile registered this Thursday a new record of daily infections, with 12,500 new infected, the highest number in the entire pandemic, in one of the countries with the highest percentage of its population vaccinated and that this Thursday began to apply the fourth dose to health personnel. (Photo by JAVIER TORRES / AFP) JAVIER TORRES
‌
‌

‌

‌
‌

‌

‌